CoChat

An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study

Open access
Heuer, Luke S., Croen, Lisa A., Jones, Karen L., Yoshida, Cathleen K., Hansen, Robin L., Yolken, Robert, Zerbo, Ousseny, DeLorenze, Gerald, Kharrazi, Martin, Ashwood, Paul, Van de Water, Judy · 2019 · Biological Psychiatry
Cited by 101

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background: The identification of an early biomarker for autism spectrum disorder (ASD) would improve the determination of risk, leading to earlier diagnosis and, potentially to earlier intervention and improved outcomes. Methods: Data were generated from the Early Markers for Autism (EMA) study, a population-based case-control study of prenatal and neonatal biomarkers of ASD. Newborn bloodspots of children with ASD (N=370), developmental delay (DD, N=140), and general population (GP, N=378) controls were analyzed for 42 different immune markers using a Luminex multiplex platform. Comparisons of immune marker concentrations between groups were examined using logistic regression and Partial Least Squares Discriminant Analysis. Results: Children with ASD had significantly increased neonatal levels of IL-6 and IL-8 compared to GP controls. An increase in IL-8 was especially significant in the ASD group with early onset compared to the GP group with an adjusted odds ratio of 1.97 (95%CI 1.39–2.83 p=0.00014). In addition, children with ASD had significantly elevated levels of Eotaxin-1, IFN-γ, and IL-12p70 relative to children with developmental delay (DD). We observed no significant differences in levels of immune markers between the DD and GP groups. Conclusion: Elevated levels of some inflammatory markers in newborn bloodspots indicated a higher degree of immune activation at birth in children who were subsequently diagnosed with ASD. The data from this exploratory study suggest that with further expansion, the development of neonatal bloodspot testing for cytokine/chemokine levels might lead to the identification of biomarkers that provide an accurate assessment of ASD risk at birth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2019.04.037

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 101

Metadata

Authors
Heuer, L. S., Croen, L. A., Jones, K. L., Yoshida, C. K., Hansen, R. L., Yolken, R., Zerbo, O., DeLorenze, G., Kharrazi, M., Ashwood, P., & Van de Water, J.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2019-08
Volume
86
Issue
4
Pages
255-264
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2946731554
Cited by
101
References
17
FWCI
7.30
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study. https://app.cochat.ai/papers/10.1016/j.biopsych.2019.04.037
The paper
Heuer, L. S., Croen, L. A., Jones, K. L., Yoshida, C. K., Hansen, R. L., Yolken, R., Zerbo, O., DeLorenze, G., Kharrazi, M., Ashwood, P., & Van de Water, J. (2019). An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study. Biological Psychiatry. https://doi.org/10.1016/j.biopsych.2019.04.037

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.